Drug Database
Back to search

Belgium· BE-AMP-SAM583351-00

Kesimpta 20 mg

A ofatumumab product containing ofatumumab, registered in Belgium by Novartis Europharm. The same ATC class is registered in 10 of our 19 countries.

ATC L04AG12

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedKesimpta 20 mgATCL04AG12REGISTER NO.BE-AMP-SAM583351-00PACKS LISTED8CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ofatumumabAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ofatumumab is registered in 10 of 19 countries.

Countries holding a registration under ATC L04AG12 (ofatumumab), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search ofatumumab products by name

Ofatumumab · ATC L04AG12

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Ofatumumab
Manufacturer
Novartis Europharm
Country
Belgium (BE)
ATC code
L04AG12
ATC class
Ofatumumab
Defined daily dose
0.67 mg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 8

4 priced
  • be_apb
    4349932
    EUR 1699.51
  • be_apb
    4637161
    EUR 1699.51
  • be_apb
    4521100
    EUR 1699.51
  • be_apb
    4911137
    EUR 1699.51
  • be_apb
    7731300
  • be_apb
    7736762
  • be_apb
    7736531
  • be_apb
    7746019

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

70 interactions on record for ofatumumab.

Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ofatumumab against other medicinesHow interaction checks work

Ofatumumab · interactions on record

70 records

  • 29 severe
  • 41 moderate

Most severe, free to view

  • CladribineL01BB04severe
  • Talimogene laherparepvecL01XL02severe
  • Talimogen laherparepvecL01XX51severe
  • LeflunomidL04AA13severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ofatumumab in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ofatumumab products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Kesimpta
  • Liechtenstein · Kesimpta
  • Norway · Kesimpta

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bdc36ee4-d5c6-405b-ac7a-35c2ea0485c6
GET /v1/drugs/bdc36ee4-d5c6-405b-ac7a-35c2ea0485c6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection in pre-filled pen",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Kesimpta 20 mg",
  "name_fr": "Kesimpta 20 mg",
  "name_nl": "Kesimpta 20 mg",
  "amp_code": "SAM583351-00",
  "strengths": [
    "50.0000",
    "50.0000"
  ],
  "pack_count": 5,
  "substances": [
    "Ofatumumab",
    "Disodium Edetate Dihydrate",
    "Sodium Acetate Trihydrate",
    "Sodium Chloride",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Ofatumumab",
  "authorisation_numbers": [
    "EU/1/21/1532/003",
    "EU/1/21/1532/004"
  ]
}
API referenceMCP serverPlans

See everything about ofatumumab.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console